Many older black women miss out on targeted breast cancer drug

(Reuters Health) - Older black women with human epidermal growth factor receptor 2 (HER2)–positive breast cancer are less likely than their white peers to receive targeted therapy with trastuzumab (Herceptin), a U.S. study suggests.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro